State Street’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.31M Buy
531,041
+133,551
+34% +$1.08M ﹤0.01% 3010
2025
Q1
$2.8M Buy
397,490
+22,210
+6% +$156K ﹤0.01% 3122
2024
Q4
$2.79M Buy
375,280
+40,920
+12% +$304K ﹤0.01% 3208
2024
Q3
$1.65M Buy
334,360
+30,916
+10% +$152K ﹤0.01% 3382
2024
Q2
$1.56M Buy
303,444
+182,487
+151% +$936K ﹤0.01% 3396
2024
Q1
$642K Buy
120,957
+2,161
+2% +$11.5K ﹤0.01% 3583
2023
Q4
$735K Hold
118,796
﹤0.01% 3548
2023
Q3
$896K Hold
118,796
﹤0.01% 3557
2023
Q2
$1.15M Sell
118,796
-370,402
-76% -$3.58M ﹤0.01% 3560
2023
Q1
$1.85M Buy
489,198
+44
+0% +$166 ﹤0.01% 3365
2022
Q4
$3.17M Sell
489,154
-8,903
-2% -$57.7K ﹤0.01% 3235
2022
Q3
$4.43M Buy
498,057
+777
+0.2% +$6.91K ﹤0.01% 3122
2022
Q2
$4.96M Buy
497,280
+14,103
+3% +$141K ﹤0.01% 3109
2022
Q1
$5.6M Buy
483,177
+15,034
+3% +$174K ﹤0.01% 3126
2021
Q4
$5.2M Sell
468,143
-44,521
-9% -$494K ﹤0.01% 3223
2021
Q3
$4.73M Sell
512,664
-18,969
-4% -$175K ﹤0.01% 3266
2021
Q2
$5.98M Buy
531,633
+44,409
+9% +$500K ﹤0.01% 3160
2021
Q1
$5.17M Sell
487,224
-43,069
-8% -$457K ﹤0.01% 3034
2020
Q4
$5.75M Sell
530,293
-27,452
-5% -$298K ﹤0.01% 2894
2020
Q3
$5.42M Sell
557,745
-13,967
-2% -$136K ﹤0.01% 2741
2020
Q2
$4.55M Buy
571,712
+2,395
+0.4% +$19.1K ﹤0.01% 2803
2020
Q1
$4.95M Sell
569,317
-24,755
-4% -$215K ﹤0.01% 2632
2019
Q4
$6.72M Buy
594,072
+12,188
+2% +$138K ﹤0.01% 2705
2019
Q3
$6.33M Buy
581,884
+6,889
+1% +$74.9K ﹤0.01% 2672
2019
Q2
$5.39M Buy
574,995
+11,370
+2% +$107K ﹤0.01% 2779
2019
Q1
$6.92M Buy
563,625
+38,268
+7% +$470K ﹤0.01% 2607
2018
Q4
$6.22M Buy
525,357
+13,100
+3% +$155K ﹤0.01% 2616
2018
Q3
$7.38M Buy
512,257
+9,752
+2% +$140K ﹤0.01% 2678
2018
Q2
$7.49M Sell
502,505
-5,741
-1% -$85.5K ﹤0.01% 2668
2018
Q1
$6.63M Buy
508,246
+950
+0.2% +$12.4K ﹤0.01% 2650
2017
Q4
$6.39M Buy
507,296
+11,596
+2% +$146K ﹤0.01% 2677
2017
Q3
$6.42M Buy
495,700
+5,107
+1% +$66.1K ﹤0.01% 2671
2017
Q2
$7.29M Buy
490,593
+37,247
+8% +$553K ﹤0.01% 2548
2017
Q1
$5.44M Buy
453,346
+5,943
+1% +$71.3K ﹤0.01% 2660
2016
Q4
$6.18M Buy
447,403
+16,455
+4% +$227K ﹤0.01% 2574
2016
Q3
$5.78M Buy
430,948
+2,162
+0.5% +$29K ﹤0.01% 2474
2016
Q2
$4.61M Sell
428,786
-7,459
-2% -$80.3K ﹤0.01% 2632
2016
Q1
$4.58M Buy
436,245
+699
+0.2% +$7.33K ﹤0.01% 2594
2015
Q4
$5.15M Buy
435,546
+1,669
+0.4% +$19.7K ﹤0.01% 2520
2015
Q3
$5.06M Sell
433,877
-6,468
-1% -$75.5K ﹤0.01% 2522
2015
Q2
$6.36M Buy
440,345
+6,634
+2% +$95.7K ﹤0.01% 2511
2015
Q1
$6.05M Buy
433,711
+4,795
+1% +$66.9K ﹤0.01% 2471
2014
Q4
$5.93M Sell
428,916
-6,508
-1% -$89.9K ﹤0.01% 2488
2014
Q3
$5.34M Sell
435,424
-5,549
-1% -$68K ﹤0.01% 2505
2014
Q2
$5.51M Sell
440,973
-8,164
-2% -$102K ﹤0.01% 2538
2014
Q1
$5.01M Sell
449,137
-1,288
-0.3% -$14.4K ﹤0.01% 2564
2013
Q4
$5.46M Sell
450,425
-32,412
-7% -$393K ﹤0.01% 2534
2013
Q3
$5.89M Sell
482,837
-20,879
-4% -$255K ﹤0.01% 2441
2013
Q2
$6.66M Buy
+503,716
New +$6.66M ﹤0.01% 2290